Cargando…
Total parenteral nutrition-associated cholestasis and risk factors in preterm infants
BACKGROUND/AIM: Development of hepatic dysfunction is a well-recognized complication of total parenteral nutrition in preterm infants. Previous studies reported the incidence of total parenteral nutrition–associated cholestasis and described possible contributing factors to its pathogenesis, but lit...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196344/ https://www.ncbi.nlm.nih.gov/pubmed/25253364 http://dx.doi.org/10.4103/1319-3767.141688 |
_version_ | 1782339465360965632 |
---|---|
author | Alkharfy, Turki M. Ba-Abbad, Rubana Hadi, Anjum Sobaih, Badr H. AlFaleh, Khalid M. |
author_facet | Alkharfy, Turki M. Ba-Abbad, Rubana Hadi, Anjum Sobaih, Badr H. AlFaleh, Khalid M. |
author_sort | Alkharfy, Turki M. |
collection | PubMed |
description | BACKGROUND/AIM: Development of hepatic dysfunction is a well-recognized complication of total parenteral nutrition in preterm infants. Previous studies reported the incidence of total parenteral nutrition–associated cholestasis and described possible contributing factors to its pathogenesis, but little is done trying to determine its possible predictive risk factors. The aims of this study was to determine the incidence of total parenteral nutrition–associated cholestasis and to develop a possible predictive model for its occurrence. PATIENTS AND METHODS: A review of medical records of all very low birth weight infants admitted to neonatal intensive care unit at King Khalid University Hospital, Riyadh, Saudi Arabia, between January 2001 and December 2003 was carried out. The infants were divided into two groups: Cholestasis and noncholestasis, based on direct serum bilirubin level >34 μmol/L. A multivariate logistic regression analysis was performed to calculate the statistical significance of risk factors. Receiver–operating characteristic curve was used to determine the optimal cutoff points for the significant risk factors and to calculate their sensitivity and specificity. The level of significance was set at P ≤ 0.05. RESULTS: A total of 307 patients were included in the analysis. The incidence of cholestasis in the whole population was 24.1% (74 patients). Infants with cholestasis had a lower birth weight, 735.4 ± 166.4 g vs. 1185.0 ± 205.6 g for noncholestasis group (P < 0.001), whereas the mean gestational age for the two groups was 25.4 ± 2.1 week and 28.9 ± 2.1 week, respectively (P < 0.001). The significant risk factors for the development of cholestasis were birth weight (P = 0.006) with an odds ratio of 0.99 [95% confidence interval (CI), 0.98, 0.99]; sensitivity of 92%, specificity of 87%; and total parenteral nutrition duration (P < 0.001) with an odds ratio of 1.18 (95% CI, 1.10, 1.27); sensitivity of 96%, specificity of 89%. CONCLUSIONS: A lower birth weight and longer duration of total parenteral nutrition were strong predictive risk factors for the development of cholestasis in preterm infants. |
format | Online Article Text |
id | pubmed-4196344 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-41963442014-10-17 Total parenteral nutrition-associated cholestasis and risk factors in preterm infants Alkharfy, Turki M. Ba-Abbad, Rubana Hadi, Anjum Sobaih, Badr H. AlFaleh, Khalid M. Saudi J Gastroenterol Original Article BACKGROUND/AIM: Development of hepatic dysfunction is a well-recognized complication of total parenteral nutrition in preterm infants. Previous studies reported the incidence of total parenteral nutrition–associated cholestasis and described possible contributing factors to its pathogenesis, but little is done trying to determine its possible predictive risk factors. The aims of this study was to determine the incidence of total parenteral nutrition–associated cholestasis and to develop a possible predictive model for its occurrence. PATIENTS AND METHODS: A review of medical records of all very low birth weight infants admitted to neonatal intensive care unit at King Khalid University Hospital, Riyadh, Saudi Arabia, between January 2001 and December 2003 was carried out. The infants were divided into two groups: Cholestasis and noncholestasis, based on direct serum bilirubin level >34 μmol/L. A multivariate logistic regression analysis was performed to calculate the statistical significance of risk factors. Receiver–operating characteristic curve was used to determine the optimal cutoff points for the significant risk factors and to calculate their sensitivity and specificity. The level of significance was set at P ≤ 0.05. RESULTS: A total of 307 patients were included in the analysis. The incidence of cholestasis in the whole population was 24.1% (74 patients). Infants with cholestasis had a lower birth weight, 735.4 ± 166.4 g vs. 1185.0 ± 205.6 g for noncholestasis group (P < 0.001), whereas the mean gestational age for the two groups was 25.4 ± 2.1 week and 28.9 ± 2.1 week, respectively (P < 0.001). The significant risk factors for the development of cholestasis were birth weight (P = 0.006) with an odds ratio of 0.99 [95% confidence interval (CI), 0.98, 0.99]; sensitivity of 92%, specificity of 87%; and total parenteral nutrition duration (P < 0.001) with an odds ratio of 1.18 (95% CI, 1.10, 1.27); sensitivity of 96%, specificity of 89%. CONCLUSIONS: A lower birth weight and longer duration of total parenteral nutrition were strong predictive risk factors for the development of cholestasis in preterm infants. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4196344/ /pubmed/25253364 http://dx.doi.org/10.4103/1319-3767.141688 Text en Copyright: © Saudi Journal of Gastroenterology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Alkharfy, Turki M. Ba-Abbad, Rubana Hadi, Anjum Sobaih, Badr H. AlFaleh, Khalid M. Total parenteral nutrition-associated cholestasis and risk factors in preterm infants |
title | Total parenteral nutrition-associated cholestasis and risk factors in preterm infants |
title_full | Total parenteral nutrition-associated cholestasis and risk factors in preterm infants |
title_fullStr | Total parenteral nutrition-associated cholestasis and risk factors in preterm infants |
title_full_unstemmed | Total parenteral nutrition-associated cholestasis and risk factors in preterm infants |
title_short | Total parenteral nutrition-associated cholestasis and risk factors in preterm infants |
title_sort | total parenteral nutrition-associated cholestasis and risk factors in preterm infants |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196344/ https://www.ncbi.nlm.nih.gov/pubmed/25253364 http://dx.doi.org/10.4103/1319-3767.141688 |
work_keys_str_mv | AT alkharfyturkim totalparenteralnutritionassociatedcholestasisandriskfactorsinpreterminfants AT baabbadrubana totalparenteralnutritionassociatedcholestasisandriskfactorsinpreterminfants AT hadianjum totalparenteralnutritionassociatedcholestasisandriskfactorsinpreterminfants AT sobaihbadrh totalparenteralnutritionassociatedcholestasisandriskfactorsinpreterminfants AT alfalehkhalidm totalparenteralnutritionassociatedcholestasisandriskfactorsinpreterminfants |